Experiencia de una institución argentina en tumores neuroendocrinos de cérvix

Sofía Pujovich; Elías Ortega Chahla; Andrés Gil; Fernanda Alsina; Diego Prost

doi:10.56969/oc.v22i1.74

Autores/as

Sofía Pujovich Departamento de Clínica Oncológica, Instituto de Oncología Ángel H. Roffo, Buenos Aires
Elías Ortega Chahla Departamento de Clínica Oncológica, Instituto de Oncología Ángel H. Roffo, Buenos Aires
Andrés Gil Departamento de Radioterapia, Instituto de Oncología Ángel H. Roffo, Buenos Aires
Fernanda Alsina Departamento de Patología, Instituto de Oncología Ángel H. Roffo, Buenos Aires
Diego Prost Instituto de Oncología Ángel H. Roffo, Buenos Aires https://orcid.org/0000-0002-4962-8611

DOI:

https://doi.org/10.56969/oc.v22i1.74

Palabras clave:

carcinoma neuroendocrino, cuello uterino, quimioterapia, radioterapia, neuroendocrine carcinoma, cervical cancer, chemotherapy, radiotherapy

Resumen

El cáncer de cuello uterino es de alta prevalencia en nuestra comunidad. El subtipo escamoso tiene directa relación con factores socio- económicos. Los tumores neuroendocrinos son la variedad menos frecuente y no presentan un claro agente causal. En este trabajo se analizan los casos identificados en nuestro instituto en la última década, enfocándonos en los aspectos de presentación de la enfermedad y rasgos sociales.

Citas

Margolis B, Tergas AI, Chen L, et al, Natural history and outcome of neuroendocrine carcinoma of the cervix. Gynecol Oncol 2016; 141:247-54. DOI: https://doi.org/10.1016/j.ygyno.2016.02.008

Albores-Saavedra J, Larraza O, Poucell S, Rodriguez Martinez HA. Carcinoid of the uterine cervix: additional observations on a new tumor entity. Cancer 1976; 38:2328-42. DOI: https://doi.org/10.1002/1097-0142(197612)38:6<2328::AID-CNCR2820380620>3.0.CO;2-J

Siriaunkgul S, Utaipat U, Settakorn J, Sukpan K, Srisomboon J, Khunamornpong S. HPV genotyping in neuroendocrine carcinoma of the uterine cervix in northern Thailand. Int J Gynaecol Obstet 2011; 115:175-9. DOI: https://doi.org/10.1016/j.ijgo.2011.06.010

Cohen JG, Kapp DS, Shin JY, et al. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. Am J Obstet Gynecol 2010; 203: 347. DOI: https://doi.org/10.1016/j.ajog.2010.04.019

Miller B, Dockter M, el Torky M, Photopulos G. Small cell carcinoma of the cervix: a clinical and flow-cytometric study. Gynecol Oncol 1991; 42:27-33. DOI: https://doi.org/10.1016/0090-8258(91)90225-T

Kasamatsu T, Sasajima Y, Onda T, Sawada M, Kato T, Tanikawa M. Surgical treatment for neuroendocrine carcinoma of the uterine cervix. Int J Gynaecol Obstet 2007; 99:225-8. DOI: https://doi.org/10.1016/j.ijgo.2007.06.051

McCusker ME, Coté TR, Clegg LX, Tavassoli FJ. Endocrine tumors of the uterine cervix: incidence, demographics, and survival with comparison to squamous cell carcinoma. Gynecol Oncol 2003; 88:333-9. DOI: https://doi.org/10.1016/S0090-8258(02)00150-6

Boruta DM 2nd, Schorge JO, Duska LA, Crum CP, Castrillon DH. Sheets, EE. Multimodality therapy in early- stage neuroendocrine carcinoma of the uterine cervix. Gynecol Oncol 2001; 81:82-7. DOI: https://doi.org/10.1006/gyno.2000.6118

Ganesan R, Hirschowitz L, Dawson P, et al. Neuroendocrine carcinoma of the cervix: review of a series of cases and correlation with outcome. Int J Surg Pathol 2016; 24:490-6. DOI: https://doi.org/10.1177/1066896916643385

Burzawa J, Gonzales N, Frumovitz M. Challenges in the diagnosis and management of cervical neuroendocrine carcinoma. Expert Rev Anticancer Ther 2015; 15:805-10. DOI: https://doi.org/10.1586/14737140.2015.1047767

Nagao S, Miwa M, Maeda N, et al. Clinical features of neuroendocrine carcinoma of the uterine cervix: a single- institution retrospective review. Int J Gynecol Cancer 2015; 25:1300-5. DOI: https://doi.org/10.1097/IGC.0000000000000495